Carle Cancer Center 509 W. University Avenue — Urbana, Illinois

Carle Cancer Center 509 W. University Avenue is a clinical research site located in Urbana, Illinois, United States 61801.

Crixeo Clinical Trials Trust Score: 94/100 (GOOD). This profile has not yet been claimed by the site owner.

Carle Cancer Center 509 W. University Avenue has participated in 1 clinical trials.

Therapeutic areas: Unresectable, Recurrent, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer Third Line.

Sponsors: EMD Serono Research & Development Institute, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Urbana

Browse all research sites in Illinois · View every site in Urbana

Sponsor Feasibility Report

Trust Score: 94/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Carle Cancer Center 509 W. University Avenue?

Carle Cancer Center 509 W. University Avenue has a Crixeo Trust Score of 94/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Carle Cancer Center 509 W. University Avenue conducted?

Carle Cancer Center 509 W. University Avenue has 1 clinical trials on record. Their work covers Unresectable, Recurrent, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer Third Line.

Is Carle Cancer Center 509 W. University Avenue accredited by Crixeo Clinical Trials?

Carle Cancer Center 509 W. University Avenue has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Carle Cancer Center 509 W. University Avenue?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.